SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Life inks $80 million supply deal

16 Aug 2011 Evaluate

Jubilant Life Sciences has signed a long-term supply agreement in proprietary products business with a leading international life sciences company. The total contract is valued at over $80 million to be executed in three years beginning the April–June 2012 quarter.

According to the company, the product has a huge demand in the market and has already received advance payment from its customer on the signing of the deal. The product would be made using its in-house technology and raw material to make it cost-effective. This contract has a minimum volume ‘take or pay’ commitment and has an opportunity to go over $100 million. crackcrack

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×